Filing Details
- Accession Number:
- 0001140361-18-030198
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-27 19:00:11
- Reporting Period:
- 2018-06-26
- Accepted Time:
- 2018-06-27 19:00:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1012477 | Avadel Pharmaceuticals Plc | AVDL | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1410677 | J Greg Divis | C/O Avadel Pharmaceuticals Plc Block 10-1 Blanchardstown Corporate Park Dublin L2 15 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Adss | Acquisiton | 2018-06-26 | 16,000 | $6.00 | 49,100 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Adss | Stock Option (right to buy) | $10.40 | 2026-12-14 | 150,000 | 150,000 | Direct | |
| Adss | Stock Option (right to buy) | $8.95 | 2027-12-12 | 100,000 | 100,000 | Direct | |
| Adss | Stock Option (right to buy) | $7.06 | 2028-03-22 | 50,000 | 50,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2026-12-14 | 150,000 | 150,000 | Direct |
| 2027-12-12 | 100,000 | 100,000 | Direct |
| 2028-03-22 | 50,000 | 50,000 | Direct |
Footnotes
- The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
- Includes 22,500 restricted shares granted under the issuer's Omnibus Incentive Compensation Plan on 12/12/2017, under which 15,000 ADSs will vest and be issued on the second anniversary of the grant date and the remaining 7,500 ADSs will vest and be issued on the third anniversary of the grant date (with vesting of these restricted shares subject to the reporting person remaining in continuous service until the applicable anniversary of the date of grant).
- Options become exercisable as to 37,500 ADSs on each of the first four anniversaries after the 12/14/2016 grant date.
- Options become exercisable as to 25,000 ADSs on each of the first four anniversaries after the 12/12/2017 grant date.
- Options become exercisable as to 12,500 ADSs on each of the first four anniversaries after the 3/22/2018 grant date.
Billionaire Hedge Funds
